• Home
  • Inflammation

Upcoming webinar: Should Everyone Consider Taking the Anti-Aging Drugs Metformin and Rapamycin?

Metformin is a drug that boosts the anti-aging enzyme AMPK, and rapamycin is a drug that suppresses the pro-aging enzyme mTOR. Metformin is so powerful that, compared to individuals without diabetes, people with diabetes who take metformin live longer. Rapamycin is considered a universal anti-aging drug, extending lifespan in every animal tested. Both drugs are off-patent, inexpensive, and widely available. Do the potential upsides outweigh the risks? Find out in this live 90-minute webinar on Friday, June 14, starting at 2pm ET. Register here:

Everyone who registers for the webinar will receive the recording a few days after it takes place.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Rochester Academy of Medicine and NutritionFacts.org. The Rochester Academy of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

• Subscribe:
• Donate:
• Podcast :
• Books:
• Shop:
• Facebook:
• Twitter:
• Instagram:

Dave McKinnon

  • @Macorelppa says:

    Hell yes!

  • @TheRbraden says:

    Can’t wait. I’ve been curious about metformin after hearing Brian Johnson talk about taking it. Seems crazy, but maybe not.

  • @moresalad221 says:

    I’ve seen studies that indicate people who take metforming living longer, but it has to do with other factors.

  • @jeanneamato8278 says:

    I eat Whole Foods vegan and organic. That’s as age resistant as I want to be. Love and health to everyone. Bless Dr. Greger.

  • >